risperidone has been researched along with Convulsive Generalized Seizure Disorder in 2 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakaji, P | 1 |
| Meltzer, HS | 1 |
| Singel, SA | 1 |
| Alksne, JF | 1 |
| Dhossche, D | 1 |
| Petrides, G | 1 |
2 other studies available for risperidone and Convulsive Generalized Seizure Disorder
| Article | Year |
|---|---|
Improvement of aggressive and antisocial behavior after resection of temporal lobe tumors.
Topics: Adolescent; Aggression; Anticonvulsants; Antipsychotic Agents; Brain Neoplasms; Child Behavior Disor | 2003 |
Negative symptoms or catatonia?
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Benzodiazepinones; Child; Clobazam; Cloz | 1997 |